Strumph joins Codexis with 20 years’ experience in senior manufacturing and operations management in the biopharmaceutical industry. He was chief executive of Nile Therapeutics, a cardiovascular company, from 2007–2009. Previously, he worked for 10 years at CV Therapeutics, most recently serving as senior vice president, operations.
Strumph takes responsibility for Codexis’ pharmaceutical product management and manufacturing operations worldwide.
Codexis creates new position
Peter Strumph joins as senior vice president of commercial operations
You may also like
Ingredients
Global partnership to expand pharma biocatalysis uptake
Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading biocatalyst technology within Porton’s global custom intermediate and active pharmaceutical ingredients (API) development and manufacturing business. Dr Kevin Robinson caught up with Porton’s Oliver Ju and Codexis’ John Nicols to find our more